Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2028

Global Alpha-1 Antitrypsin Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Alpha-1 Antitrypsin Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Parenteral
1.2.3 Inhalation
1.3 Market by Application
1.3.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Alpha-1 Antitrypsin Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Alpha-1 Antitrypsin Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Alpha-1 Antitrypsin Drugs Sales by Region
2.4.1 Global Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Alpha-1 Antitrypsin Drugs by Region (2023-2028)
2.5 Global Alpha-1 Antitrypsin Drugs Revenue by Region
2.5.1 Global Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022)
2.5.2 Global Alpha-1 Antitrypsin Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers
3.1.1 Global Top Alpha-1 Antitrypsin Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alpha-1 Antitrypsin Drugs in 2021
3.2 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers
3.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Drugs Revenue in 2021
3.3 Global Alpha-1 Antitrypsin Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Alpha-1 Antitrypsin Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Alpha-1 Antitrypsin Drugs Sales by Type
4.1.1 Global Alpha-1 Antitrypsin Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Alpha-1 Antitrypsin Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
4.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type
4.2.1 Global Alpha-1 Antitrypsin Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Alpha-1 Antitrypsin Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Alpha-1 Antitrypsin Drugs Price by Type
4.3.1 Global Alpha-1 Antitrypsin Drugs Price by Type (2017-2022)
4.3.2 Global Alpha-1 Antitrypsin Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Alpha-1 Antitrypsin Drugs Sales by Application
5.1.1 Global Alpha-1 Antitrypsin Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Alpha-1 Antitrypsin Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
5.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application
5.2.1 Global Alpha-1 Antitrypsin Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Alpha-1 Antitrypsin Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Alpha-1 Antitrypsin Drugs Price by Application
5.3.1 Global Alpha-1 Antitrypsin Drugs Price by Application (2017-2022)
5.3.2 Global Alpha-1 Antitrypsin Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Alpha-1 Antitrypsin Drugs Market Size by Type
6.1.1 North America Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
6.1.2 North America Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
6.2 North America Alpha-1 Antitrypsin Drugs Market Size by Application
6.2.1 North America Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
6.2.2 North America Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
6.3 North America Alpha-1 Antitrypsin Drugs Market Size by Country
6.3.1 North America Alpha-1 Antitrypsin Drugs Sales by Country (2017-2028)
6.3.2 North America Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Alpha-1 Antitrypsin Drugs Market Size by Type
7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
7.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
7.2 Europe Alpha-1 Antitrypsin Drugs Market Size by Application
7.2.1 Europe Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
7.2.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
7.3 Europe Alpha-1 Antitrypsin Drugs Market Size by Country
7.3.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2017-2028)
7.3.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size by Type
8.1.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size by Application
8.2.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size by Region
8.3.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Alpha-1 Antitrypsin Drugs Market Size by Type
9.1.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
9.1.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
9.2 Latin America Alpha-1 Antitrypsin Drugs Market Size by Application
9.2.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
9.2.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
9.3 Latin America Alpha-1 Antitrypsin Drugs Market Size by Country
9.3.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2017-2028)
9.3.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Type
10.1.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Application
10.2.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Country
10.3.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Overview
11.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Baxter Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 CSL Behring
11.2.1 CSL Behring Corporation Information
11.2.2 CSL Behring Overview
11.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Behring Recent Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Overview
11.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Grifols Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Kamada
11.4.1 Kamada Corporation Information
11.4.2 Kamada Overview
11.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kamada Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kamada Recent Developments
11.5 Abeona Therapeutics
11.5.1 Abeona Therapeutics Corporation Information
11.5.2 Abeona Therapeutics Overview
11.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abeona Therapeutics Recent Developments
11.6 Alnylam Pharmaceuticals
11.6.1 Alnylam Pharmaceuticals Corporation Information
11.6.2 Alnylam Pharmaceuticals Overview
11.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Alnylam Pharmaceuticals Recent Developments
11.7 Applied Genetic Technologies Corp
11.7.1 Applied Genetic Technologies Corp Corporation Information
11.7.2 Applied Genetic Technologies Corp Overview
11.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Applied Genetic Technologies Corp Recent Developments
11.8 Arrowhead Research Corporation
11.8.1 Arrowhead Research Corporation Corporation Information
11.8.2 Arrowhead Research Corporation Overview
11.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Arrowhead Research Corporation Recent Developments
11.9 Baxalta
11.9.1 Baxalta Corporation Information
11.9.2 Baxalta Overview
11.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Baxalta Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Baxalta Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Alpha-1 Antitrypsin Drugs Industry Chain Analysis
12.2 Alpha-1 Antitrypsin Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Alpha-1 Antitrypsin Drugs Production Mode & Process
12.4 Alpha-1 Antitrypsin Drugs Sales and Marketing
12.4.1 Alpha-1 Antitrypsin Drugs Sales Channels
12.4.2 Alpha-1 Antitrypsin Drugs Distributors
12.5 Alpha-1 Antitrypsin Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Alpha-1 Antitrypsin Drugs Industry Trends
13.2 Alpha-1 Antitrypsin Drugs Market Drivers
13.3 Alpha-1 Antitrypsin Drugs Market Challenges
13.4 Alpha-1 Antitrypsin Drugs Market Restraints
14 Key Findings in The Global Alpha-1 Antitrypsin Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Parenteral
Table 3. Major Manufacturers of Inhalation
Table 4. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022) & (K Units)
Table 7. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Alpha-1 Antitrypsin Drugs Sales by Region (2023-2028) & (K Units)
Table 9. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Alpha-1 Antitrypsin Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Alpha-1 Antitrypsin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2021)
Table 21. Alpha-1 Antitrypsin Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Alpha-1 Antitrypsin Drugs Product Offered
Table 23. Date of Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 26. Global Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
Table 27. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2017-2022)
Table 28. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2023-2028)
Table 29. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2017-2022)
Table 32. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2023-2028)
Table 33. Alpha-1 Antitrypsin Drugs Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Alpha-1 Antitrypsin Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 36. Global Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
Table 37. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2017-2022)
Table 38. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2023-2028)
Table 39. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Alpha-1 Antitrypsin Drugs Revenue Share by Application (2017-2022)
Table 42. Global Alpha-1 Antitrypsin Drugs Revenue Share by Application (2023-2028)
Table 43. Alpha-1 Antitrypsin Drugs Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Alpha-1 Antitrypsin Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 46. North America Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
Table 47. North America Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 50. North America Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
Table 51. North America Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 54. North America Alpha-1 Antitrypsin Drugs Sales by Country (2023-2028) & (K Units)
Table 55. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 58. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
Table 59. Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 62. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
Table 63. Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 66. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2023-2028) & (K Units)
Table 67. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Baxter Corporation Information
Table 106. Baxter Description and Major Businesses
Table 107. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Baxter Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Baxter Recent Developments
Table 110. CSL Behring Corporation Information
Table 111. CSL Behring Description and Major Businesses
Table 112. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. CSL Behring Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. CSL Behring Recent Developments
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Major Businesses
Table 117. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Grifols Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Grifols Recent Developments
Table 120. Kamada Corporation Information
Table 121. Kamada Description and Major Businesses
Table 122. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Kamada Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Kamada Recent Developments
Table 125. Abeona Therapeutics Corporation Information
Table 126. Abeona Therapeutics Description and Major Businesses
Table 127. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Abeona Therapeutics Recent Developments
Table 130. Alnylam Pharmaceuticals Corporation Information
Table 131. Alnylam Pharmaceuticals Description and Major Businesses
Table 132. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Alnylam Pharmaceuticals Recent Developments
Table 135. Applied Genetic Technologies Corp Corporation Information
Table 136. Applied Genetic Technologies Corp Description and Major Businesses
Table 137. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Applied Genetic Technologies Corp Recent Developments
Table 140. Arrowhead Research Corporation Corporation Information
Table 141. Arrowhead Research Corporation Description and Major Businesses
Table 142. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Arrowhead Research Corporation Recent Developments
Table 145. Baxalta Corporation Information
Table 146. Baxalta Description and Major Businesses
Table 147. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Baxalta Alpha-1 Antitrypsin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Baxalta Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Alpha-1 Antitrypsin Drugs Distributors List
Table 153. Alpha-1 Antitrypsin Drugs Customers List
Table 154. Alpha-1 Antitrypsin Drugs Market Trends
Table 155. Alpha-1 Antitrypsin Drugs Market Drivers
Table 156. Alpha-1 Antitrypsin Drugs Market Challenges
Table 157. Alpha-1 Antitrypsin Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha-1 Antitrypsin Drugs Product Picture
Figure 3. Global Alpha-1 Antitrypsin Drugs Market Share by Type in 2021 & 2028
Figure 3. Parenteral Product Picture
Figure 4. Inhalation Product Picture
Figure 5. Global Alpha-1 Antitrypsin Drugs Market Share by Application in 2021 & 2028
Figure 6. Drugstore
Figure 7. Hospital
Figure 8. Others
Figure 9. Alpha-1 Antitrypsin Drugs Report Years Considered
Figure 10. Global Alpha-1 Antitrypsin Drugs Sales 2017-2028 (K Units)
Figure 11. Global Alpha-1 Antitrypsin Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Alpha-1 Antitrypsin Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
Figure 17. North America Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Alpha-1 Antitrypsin Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Alpha-1 Antitrypsin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Alpha-1 Antitrypsin Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Alpha-1 Antitrypsin Drugs in the World: Market Share by Alpha-1 Antitrypsin Drugs Revenue in 2021
Figure 28. Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
Figure 32. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
Figure 33. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
Figure 36. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America Alpha-1 Antitrypsin Drugs Sales Share by Country (2017-2028)
Figure 38. North America Alpha-1 Antitrypsin Drugs Revenue Share by Country (2017-2028)
Figure 39. U.S. Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
Figure 42. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
Figure 43. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
Figure 45. Europe Alpha-1 Antitrypsin Drugs Sales Share by Country (2017-2028)
Figure 46. Europe Alpha-1 Antitrypsin Drugs Revenue Share by Country (2017-2028)
Figure 47. Germany Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. France Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Alpha-1 Antitrypsin Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Alpha-1 Antitrypsin Dru

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs